Open Date: September, 07 2017
Earliest Submission Date: December 16, 2017
Letter of Intent Due Date: October 15, 2017
Application Due Date: January 16, 2017
The purpose of this Funding Opportunity Announcement (FOA) is to encourage cooperative agreement (U54) applications from multidisciplinary groups of investigators to accelerate the rate of progress in determining the functional, pharmacological, neuronal network and whole animal consequences of genetic variants discovered in patients with various types of epilepsy and to develop strategies for establishing diagnostic criteria and identifying potential targets for intervention.